Table 2.
Baseline Clinical Characteristics of Sample (N=40)
| N (%) | Mean (SD) | |
|---|---|---|
| Medical History (N=37) | ||
| Alcohol abuse/dependence* | 19 (51%) | |
| Drug abuse/dependence* | 17 (46%) | |
| Allergies | 14 (38%) | |
| Endocrinopathy | 5 (14%) | |
| Lung disease | 4 (11%) | |
| Hypertension | 2 (5%) | |
| Renal disease | 2 (5%) | |
| Gastrointestinal disease | 2 (5%) | |
| Neoplastic disease | 1 (3%) | |
| Skin disease | 1 (3%) | |
| Hematologic disease | 1 (3%) | |
| Psychiatric History | ||
| History of psychiatric hospitalization | 35 (88%) | |
| Number of hospitalizations | 3.2 (3.7) | |
| History of suicide attempt (N=39) | 14 (36%) | |
| Number suicide attempts | 1.1 (2.6) | |
| Psychotropic medication during study | ||
| Antidepressants | 20 (50%) | |
| Selective serotonin reuptake inhibitors | 10 (25%) | |
| Other antidepressant | 16 (40%) | |
| Mood Stabilizers | 18 (45%) | |
| Lithium | 13 (33%) | |
| Lamotrigine | 5 (13%) | |
| Valproic acid derivative | 3 (8%) | |
| Carbamazepine | 1 (3%) | |
| Antipsychotics | 25 (63%) | |
| First generation antipsychotic | 3 (8%) | |
| Second generation antipsychotic | 24 (60%) | |
| Benzodiazepine | 15 (38%) |
*
History of abuse/dependence, individuals with active abuse/dependence were excluded.